1. Maternal Participants: a)Pregnant women, ages 15 years and older, who reside in a geographic area accessible to one of the selected clinical research sites in Brazil, Puerto Rico, and the continental United States, meet the criteria for ZIKV infection risk, are less than 18 weeks GA and are HIV-infected or uninfected (the latter in the continental U.S. only).